1. Home
  2. RYTM vs BOKF Comparison

RYTM vs BOKF Comparison

Compare RYTM & BOKF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • BOKF
  • Stock Information
  • Founded
  • RYTM 2008
  • BOKF 1910
  • Country
  • RYTM United States
  • BOKF United States
  • Employees
  • RYTM N/A
  • BOKF N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • BOKF Major Banks
  • Sector
  • RYTM Health Care
  • BOKF Finance
  • Exchange
  • RYTM Nasdaq
  • BOKF Nasdaq
  • Market Cap
  • RYTM 6.4B
  • BOKF 6.7B
  • IPO Year
  • RYTM 2017
  • BOKF N/A
  • Fundamental
  • Price
  • RYTM $98.54
  • BOKF $108.62
  • Analyst Decision
  • RYTM Strong Buy
  • BOKF Hold
  • Analyst Count
  • RYTM 12
  • BOKF 10
  • Target Price
  • RYTM $117.00
  • BOKF $115.70
  • AVG Volume (30 Days)
  • RYTM 629.6K
  • BOKF 373.2K
  • Earning Date
  • RYTM 11-04-2025
  • BOKF 10-20-2025
  • Dividend Yield
  • RYTM N/A
  • BOKF 2.31%
  • EPS Growth
  • RYTM N/A
  • BOKF 15.51
  • EPS
  • RYTM N/A
  • BOKF 8.40
  • Revenue
  • RYTM $174,334,000.00
  • BOKF $2,107,957,000.00
  • Revenue This Year
  • RYTM $46.10
  • BOKF $7.16
  • Revenue Next Year
  • RYTM $63.02
  • BOKF $6.38
  • P/E Ratio
  • RYTM N/A
  • BOKF $13.01
  • Revenue Growth
  • RYTM 54.92
  • BOKF 5.14
  • 52 Week Low
  • RYTM $45.91
  • BOKF $85.08
  • 52 Week High
  • RYTM $116.00
  • BOKF $121.58
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 39.87
  • BOKF 52.27
  • Support Level
  • RYTM $95.27
  • BOKF $105.60
  • Resistance Level
  • RYTM $102.20
  • BOKF $109.56
  • Average True Range (ATR)
  • RYTM 4.86
  • BOKF 2.54
  • MACD
  • RYTM -1.75
  • BOKF 0.52
  • Stochastic Oscillator
  • RYTM 17.51
  • BOKF 72.93

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

Share on Social Networks: